drugset / Trial / NCT06673667
First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
RandomizedSequentialDouble-blindOther
Summary
This is a first-in-human study to evaluate safety, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-621 in healthy male and female adult participants.
Timeline
- Start
- 2024-10-22
- Primary completion
- 2025-04-23
- Completion
- 2025-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | KT-621 | Unknown | — | Oral |
Indications
No indication recorded.